Company news
Seikagaku Corporation (TSE:4548) news
Seikagaku Corporation news releases on 6ix. Latest, Sep 24, 2026: Seikagaku Announces Revised Full-Year Consolidated and Non-Consolidated Earnings Forecasts…
Press releases & updates
Seikagaku Announces Revised Full-Year Consolidated and Non-Consolidated Earnings Forecasts and Dividend Forecast
September 24, 2026
Seikagaku Announces Receipt of a Complete Response Letter Concerning the Biologics License Application in the U.S. for SI-6603
September 10, 2026
[Summary] Consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)
August 5, 2026
Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
July 9, 2026
Notice Concerning Disposal of Treasury Shares as Restricted Stock Compensation
June 19, 2026
Seikagaku : Convocation Notice of the 80th Ordinary General Meeting of Shareholders
May 20, 2026
Seikagaku : Financial Results for the Fiscal Year 2025
May 14, 2026
Seikagaku : Consolidated Financial Results (Summary) for Fiscal 2025(Year Ended March 31, 2026)
May 13, 2026
Seikagaku : Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 (Under Japanese GAAP)
May 13, 2026
Seikagaku : Announces Differences between Full-Year Financial Forecasts
May 13, 2026
Seikagaku : Consolidated Financial Results (Summary) for the Third Quarter of Fiscal Year Ending March 31,2026 (Nine-Month Period Ended December 31, 2025)
February 6, 2026
Seikagaku : Announces Revision of Full-Year Consolidated Earnings Forecast, and Announcement of Full-Year Non-Consolidated Earnings Forecast
February 6, 2026
Seikagaku : Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)
February 6, 2026
Seikagaku : Financial Results for the Second Quarter of Fiscal Year 2025
November 12, 2025
Seikagaku : Consolidated Financial Results (Summary) for the Second Quarter of Fiscal Year Ending March 31,2026 (Six-Month Period Ended September 30, 2025)
November 10, 2025
Seikagaku : Announces an Application for Marketing Approval of SI-449, an Adhesion Barrier, as a Medical Device in Japan
August 20, 2025
Seikagaku : Financial Results for the First Quarter of Fiscal Year 2025
August 5, 2025
Seikagaku : Consolidated Financial Results (Summary) for the First Three Months of Fiscal 2025 (Three-Month Period Ended June 30, 2025)
August 5, 2025
Seikagaku : Consolidated Financial Results (Japan GAAP) (Summary) for the First Three Months of Fiscal 2025 (Three-Month Period Ended June 30, 2025)
August 5, 2025
Seikagaku : Convocation Notice of the 79th Ordinary General Meeting of Shareholders
May 21, 2025
Seikagaku : Financial Results for the Fiscal Year 2024
May 15, 2025
Seikagaku : Consolidated Financial Results (Summary) for Fiscal 2024(Year Ended March 31, 2025)
May 13, 2025
Seikagaku : Consolidated Financial Results (Japan GAAP) (Summary) for the Fiscal 2024 (Year Ended March 31, 2025)
May 13, 2025
Seikagaku : Announces Revision of Forecast of Full-Year Consolidated Financial Results for the Fiscal Year Ending March 31, 2025
March 26, 2025
Seikagaku Announces Receipt of a Complete Response Letter Concerning the Biologics License Application in the U.S. for SI-6603 (Generic Name: Condoliase)
March 12, 2025
Seikagaku : Announces Initiation of Phase III Clinical Studies of Gel-OneⓇ, a Treatment of Osteoarthritis, in Japan
February 21, 2025
Seikagaku : Consolidated Financial Results (Summary) for the Third Quarter of Fiscal Year Ending March 31,2025 (Nine-Month Period Ended December 31, 2024)
February 7, 2025